Infectious Disease and Microbiology – Parainfluenza Virus

Overview

Human parainfluenza viruses (HPIVs) are enveloped, single-stranded RNA viruses that are major causes of respiratory tract infection, particularly in children. Types 1–4 cause human disease.

The most characteristic clinical association is laryngotracheobronchitis (croup), which presents with a barking cough, inspiratory stridor, and hoarseness due to upper-airway inflammation and subglottic narrowing. Parainfluenza viruses can also cause ordinary upper respiratory infections, bronchiolitis, and pneumonia, with potentially severe disease in immunocompromised individuals.

Classification

Virus group: Human parainfluenza viruses (HPIVs)

Types: HPIV-1, HPIV-2, HPIV-3, and HPIV-4

Order: Mononegavirales

Virus type: Enveloped, negative-sense single-stranded RNA virus

Parainfluenza viruses have traditionally been grouped with the paramyxoviruses, although modern taxonomy places the human types within related genera of the family Paramyxoviridae.

Microbiologic Characteristics

Parainfluenza viruses are:

• Single-stranded RNA viruses

• Negative-sense RNA viruses

• Relatively large viruses

• Enveloped

• Characterized by helical nucleocapsid symmetry

Because they are enveloped, appropriate hand hygiene and infection-control measures are important in limiting transmission.

Viral Surface Proteins

Important viral proteins include:

Hemagglutinin-neuraminidase (HN)

→ Promotes attachment to respiratory epithelial cells

and

Fusion (F) protein

→ Promotes fusion of viral and host-cell membranes

→ Can promote formation of multinucleated giant cells or syncytia

High-Yield Microbiology Pattern

Enveloped

• ●

Negative-sense ssRNA

• ●

Helical nucleocapsid

• ●

Fusion protein

• ●

Croup

→ Think PARAINFLUENZA VIRUS

Incubation Period

The incubation period is approximately:

2–6 days

After infection, viral replication primarily involves the respiratory epithelium.

Epidemiology

Parainfluenza virus infections occur:

Worldwide

Disease may occur:

• Sporadically

• In community outbreaks

• In healthcare-associated outbreaks

Children are particularly important hosts for symptomatic infection.

Transmission

Transmission occurs primarily through:

Respiratory secretions

and close contact with infected individuals or contaminated hands and surfaces.

Transmission Pattern

Infected respiratory secretions

↓

Exposure of susceptible person

↓

Respiratory epithelial infection

↓

Upper and/or lower respiratory tract disease

Croup

The classic disease caused by parainfluenza virus is:

Laryngotracheobronchitis

also known as:

CROUP

Parainfluenza viruses are among the most important viral causes of croup in children.

Pathogenesis of Croup

Parainfluenza infection

↓

Inflammation of larynx and trachea

↓

Subglottic edema

↓

Narrowing of upper airway

↓

Characteristic:

Barking cough + inspiratory stridor + hoarseness

Clinical Manifestations of Croup

The classic findings include:

• Barking or “seal-like” cough

• Inspiratory stridor

• Hoarseness

• Fever

• Upper respiratory symptoms

• Variable respiratory distress

Severe airway narrowing can cause significant respiratory compromise.

High-Yield Clinical Triad

Barking cough

• ●

Inspiratory stridor

• ●

Hoarseness

→ CROUP

→ Think PARAINFLUENZA VIRUS

Steeple Sign

Neck radiography, when obtained, may demonstrate:

Subglottic airway narrowing

producing the classic:

“Steeple sign”

However, uncomplicated croup is usually diagnosed clinically, and imaging is not routinely required.

High-Yield Imaging Pattern

Child

• ●

Barking cough

• ●

Inspiratory stridor

• ●

Subglottic narrowing / steeple sign

→ Croup due to parainfluenza virus

Other Upper Respiratory Tract Infections

Parainfluenza viruses frequently cause other:

Upper respiratory tract infections

Possible manifestations include:

• Rhinorrhea

• Nasal congestion

• Sore throat

• Cough

• Fever

• Hoarseness

Many infections are relatively mild and self-limited.

Bronchiolitis

Parainfluenza virus can occasionally cause:

Bronchiolitis

particularly in young children.

Possible manifestations include:

• Cough

• Tachypnea

• Wheezing

• Increased work of breathing

Pneumonia

Parainfluenza can also produce:

Viral pneumonia

Although less characteristic than croup, lower respiratory disease can be clinically significant in:

• Young children

• Older adults

• Patients with chronic illness

• Immunocompromised individuals

Infection in Immunocompromised Patients

Parainfluenza infection can become particularly severe in:

Immunocompromised hosts

These patients may develop:

• Severe pneumonia

• Progressive lower respiratory tract disease

• Prolonged viral shedding

• Significant respiratory failure

For this reason, rapid molecular diagnosis may be especially useful in this population.

Parainfluenza Virus Types

The different HPIV types have somewhat different epidemiologic associations.

HPIV-1

→ Strongly associated with croup

HPIV-2

→ Also associated with croup

HPIV-3

→ More commonly associated with lower respiratory tract disease, including bronchiolitis and pneumonia

HPIV-4

→ Usually less frequently recognized and often causes respiratory illness of variable severity

Type Memory Aid

Types 1 and 2

→ CROUP

Type 3

→ BRONCHIOLITIS / PNEUMONIA

Diagnosis

Most uncomplicated cases of croup are diagnosed:

Clinically

Laboratory confirmation is generally unnecessary for typical mild disease.

Laboratory Methods

The source lists:

• Serologic testing

• Antigen detection assays

• Viral culture

• PCR

PCR

Molecular testing is particularly useful when rapid and sensitive identification is clinically important.

The source specifically emphasizes PCR in:

Immunocompromised patients

PCR-based respiratory panels can identify parainfluenza virus directly from respiratory specimens.

Treatment

Mild parainfluenza respiratory infections generally require:

Supportive and symptomatic treatment

There is no routine specific antiviral treatment for uncomplicated parainfluenza infection.

Treatment of Croup

Management depends on severity.

A central treatment for croup is:

Corticosteroid therapy

with dexamethasone commonly used to decrease airway inflammation.

Racemic Epinephrine

For patients with significant or severe croup:

Nebulized epinephrine

can rapidly reduce upper-airway obstruction by decreasing mucosal edema.

The source specifically describes:

Racemic epinephrine aerosol

for severe laryngotracheobronchitis.

Its clinical effect can be relatively short-lived, so patients with significant disease require appropriate observation and reassessment.

Severe Croup

If airway obstruction progresses despite medical therapy:

Airway support

may become necessary.

In severe cases:

Endotracheal intubation

may be required.

Croup Treatment Pattern

Mild/moderate croup

→ Corticosteroid, commonly dexamethasone

More severe croup with stridor at rest

→ Corticosteroid

+

Nebulized epinephrine

Impending respiratory failure

→ Airway management / intubation

Parainfluenza vs. RSV

Parainfluenza

→ Croup

→ Barking cough

→ Inspiratory stridor

→ Subglottic airway involvement

Respiratory syncytial virus (RSV)

→ Bronchiolitis especially in infants

→ Wheezing

→ Lower respiratory tract disease

Although both viruses can produce lower respiratory infection, their classic clinical associations differ.

Croup vs. Epiglottitis

Croup

→ Usually viral

→ Parainfluenza classic

→ Barking cough

→ Inspiratory stridor

→ Hoarseness

→ Subglottic narrowing

→ Steeple sign

Epiglottitis

→ Acute supraglottic inflammation

→ High fever and toxic appearance may occur

→ Drooling

→ Dysphagia

→ Tripod positioning

→ Airway emergency

Recognizing the distinction is clinically important because epiglottitis can require urgent airway management.

Croup vs. Bacterial Tracheitis

Viral croup

→ Barking cough and stridor

→ Usually less toxic appearing

Bacterial tracheitis

→ High fever

→ Toxic appearance

→ Progressive upper-airway obstruction

→ Thick or purulent tracheal secretions

A child who appears unusually ill for typical croup should be evaluated for alternative diagnoses.

Prevention

The source emphasizes:

Handwashing

to reduce transmission, particularly:

Nosocomial transmission

Other infection-control measures include appropriate precautions for respiratory secretions and careful hygiene around infected patients.

High-Yield Clinical Pattern

Young child

• ●

Recent upper respiratory symptoms

• ●

Barking “seal-like” cough

• ●

Inspiratory stridor

• ●

Hoarseness

→ CROUP

→ Think PARAINFLUENZA VIRUS

Exam Essentials

Virus: Human parainfluenza virus

Types: 1–4

Family: Paramyxoviridae

Genome: Negative-sense single-stranded RNA

Envelope: Present

Nucleocapsid: Helical

Incubation: 2–6 days

Distribution: Worldwide

Classic disease: Laryngotracheobronchitis (croup)

Classic symptoms: Barking cough + inspiratory stridor + hoarseness

Anatomic abnormality: Subglottic edema/narrowing

Classic radiographic association: Steeple sign

Types strongly associated with croup: HPIV-1 and HPIV-2

HPIV-3: More strongly associated with bronchiolitis and pneumonia

Other infections: URTI, bronchiolitis, pneumonia

High-risk group: Immunocompromised patients

Diagnosis: Usually clinical for uncomplicated croup; PCR is useful when laboratory confirmation is needed

Mild infection: Supportive treatment

Croup: Corticosteroid therapy

Significant/severe croup: Nebulized epinephrine + corticosteroid

Severe airway compromise: May require intubation

Routine specific antiviral therapy: None

Prevention: Hand hygiene and respiratory infection-control measures

Key clinical pearl: Parainfluenza virus is the classic viral cause of croup. A young child with a barking cough, inspiratory stridor, hoarseness, and subglottic narrowing should immediately suggest parainfluenza-associated laryngotracheobronchitis; corticosteroids reduce airway inflammation, while nebulized epinephrine is particularly useful for more severe airway obstruction.